NMTR

9 Meters Biopharma, Inc. to Present at 2021 BIO Digital

Is the Options Market Predicting a Spike in 9 Meters Biopharma (NMTR) Stock?

CORRECTION 9 Meters Biopharma, Inc. to Present at Oppenheimer's Rare & Orphan Disease Summit

9 Meters Biopharma, Inc. to Present at Oppenheimer's Rare & Orphan Disease Summit

9 Meters Biopharma, Inc. Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome

9 Meters Biopharma Provides Business Update and Reports Financial Results for the First Quarter 2021